Form D Explorer

Source evidence

511 Therapeutics, Inc. · 0001946264-26-000003

D filed Oct. 30, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
CAMBRIDGE
street1
1770 MASSACHUSETTS AVENUE
street2
#511
zipCode
02140
entityName
511 Therapeutics, Inc.
entityType
Corporation
stateOrCountry
MA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold500000number500000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount1000000number1000000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 7d555eae272db9817a9c9f3a41fa4f14d26a89bcb517a4436c332f86e8598709. This proves extraction identity, not the accuracy of the filer's claims.